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Abstract
Background: Recent studies have identified age-related changes in DNA methylation patterns in normal and
cancer tissues in a process that is called epigenetic drift. However, the evolving patterns, functional consequences,
and dynamics of epigenetic drift during carcinogenesis remain largely unexplored. Here we analyze the evolution
of epigenetic drift patterns during progression from normal squamous esophagus tissue to Barrett’s esophagus (BE)
to esophageal adenocarcinoma (EAC) using 173 tissue samples from 100 (nonfamilial) BE patients, along with
publically available datasets including The Cancer Genome Atlas (TCGA).
Results: Our analysis reveals extensive methylomic drift between normal squamous esophagus and BE
tissues in nonprogressed BE patients, with differential drift affecting 4024 (24%) of 16,984 normally
hypomethylated cytosine-guanine dinucleotides (CpGs) occurring in CpG islands. The majority (63%) of
islands that include drift CpGs are associated with gene promoter regions. Island CpGs that drift have
stronger pairwise correlations than static islands, reflecting collective drift consistent with processive DNA
methylation maintenance. Individual BE tissues are extremely heterogeneous in their distribution of
methylomic drift and encompass unimodal low-drift to bimodal high-drift patterns, reflective of differences
in BE tissue age. Further analysis of longitudinally collected biopsy samples from 20 BE patients confirm the
time-dependent evolution of these drift patterns. Drift patterns in EAC are similar to those in BE, but
frequently exhibit enhanced bimodality and advanced mode drift. To better understand the observed drift
patterns, we developed a multicellular stochastic model at the CpG island level. Importantly, we find that
nonlinear feedback in the model between mean island methylation and CpG methylation rates is able to
explain the widely heterogeneous collective drift patterns. Using matched gene expression and DNA
methylation data in EAC from TCGA and other publically available data, we also find that advanced
methylomic drift is correlated with significant transcriptional repression of ~ 200 genes in important
regulatory and developmental pathways, including several checkpoint and tumor suppressor-like genes.
Conclusions: Taken together, our findings suggest that epigenetic drift evolution acts to significantly
reduce the expression of developmental genes that may alter tissue characteristics and improve functional
adaptation during BE to EAC progression.
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Background
Research into the connection between aging and cancer is
being fueled by advances in molecular profiling of age-
related processes such as chronic inflammation, accumu-
lation of somatic DNA/mtDNA mutations, and epigenetic
changes in tissues in which cancers arise [1]. Two distinct,
albeit not entirely independent, concepts have emerged
recently that relate changes in DNA methylation to bio-
logical tissue age. The first is based on the discovery (of
sets) of CpG dinucleotides (CpGs) in the genome that are
subject to age-dependent, possibly complex changes in
methylation levels that, in aggregate, correlate strongly
with chronological age [2–4]. We refer to these types of
CpGs as clock-CpGs. A second and simpler concept is
based on the observation of gradual age-related changes
in methylation levels at specific CpG sites or CpG-rich re-
gions, a process commonly referred to as epigenetic or
methylomic drift [5–11]. For example, some CpG islands
show very low methylation levels early in life but are
known to become gradually methylated over time as a re-
sult of sporadic de novo methylation events during DNA
replication. We identify these as drift CpGs. It is worth
pointing out that data supporting these concepts come
mainly from cross-sectional studies that include individ-
uals of different age. In contrast, individual-level (longitu-
dinal) drift, unless studied directly in select individuals
over time as we have collected for this study, is typically
inferred from population drift.
In a recent study, we used a combination of cross-
sectional and longitudinally collected biopsy samples to
identify a set of highly correlated CpGs in premalignant
Barrett’s esophagus (BE) tissue that undergo differential epi-
genetic drift relative to normal squamous (NS) tissue [12].
This study arrived at a set of 67 drift CpGs that show sig-
nificant age-related methylation differences between NS
and BE and was used as an epigenetic clock to estimate the
time of BE onset. Unlike previous epigenetic clocks that
were constructed to predict the age of an individual, the BE
tissue-specific clock model was designed to infer unknown
tissue ages. Because BE is essentially asymptomatic, it is
usually not known how long a patient has lived with BE.
However, the time a patient has lived with BE may be con-
sidered a risk factor since older BE tissue has had more
time for cancer to evolve compared to younger BE tissue
which is more likely to be free of neoplastic changes [13,
14]. Although the earlier study was the first to develop an
epigenetic clock for BE tissue age, we did not evaluate the
full scope of epigenetic drift occurring in BE following its
formation, nor its dynamics or functional consequences at
the genomic level.
The aims of this study are to characterize individual het-
erogeneity and genome-wide patterns of age-related epi-
genetic drift in tissue samples from BE and EAC patients,
to develop a mechanistic understanding of methylation
dynamics during tissue aging, including the degree of
cooperativity and possible presence of nonlinear feedback
within CpG islands during the temporal evolution of epi-
genetic drift, and to explore the impact of advanced drift
on gene expression in EACs for which we have both gene
expression and methylation data.
To accomplish the aims of this study, it was necessary
to analyze methylation drift patterns from an extensive
collection of NS, BE, and EAC biopsy tissue samples, in-
cluding 173 tissue samples from 100 nonprogressed and
progressed (nonfamilial) BE patients, along with methy-
lation and gene expression data in 87 EAC from The
Cancer Genome Atlas (TCGA) [15] and in 47 EAC + 4
BE samples previously analyzed by Krause et al. [16].
Results
Using data from the HM450 methylation arrays (see
“Methods”), we aimed to better characterize the full extent
of epigenetic drift occurring in BE and the temporal dy-
namics of epigenetic drift and to explore the impact of ad-
vanced drift on gene expression in EAC for which we have
both gene expression and methylation data. Methylation
levels are measured either in terms of a β value (methyla-
tion fraction) orM value (logit2(β)) as indicated in the text.
Genomic scope of drift
Out of 146,029 hypomethylated CpG probes in normal
squamous (NS) tissue, we identified 18,013 (12%) probes
that have significant positive correlation and 560 (0.4%) that
have a significant negative correlation (q < 0.01) with the
mean differential drift (relative to NS levels) of 67 previ-
ously validated drift CpGs in 64 BE samples from patients
without a diagnosis of dysplasia or cancer (see “Methods”).
In contrast, out of 133,857 CpG probes that were hyper-
methylated in NS tissue, only 795 (0.6%) probes correlated
positively and 3402 (2.5%) probes correlated negatively with
the mean methylation drift levels of our 67 probe reference
clock (Fig. 1). Thus, significant differential drift in BE in-
volves thousands of CpGs, occurring predominantly in
hypomethylated regions that are associated with CpG
islands, affecting 4024 (24%) of the 16,984 hypomethylated
CpG islands in NS tissue. In contrast, we found only 7% of
the identified drift CpG probes to be “open sea,” i.e., iso-
lated in the genome [17], compared to about 10% in the
hypomethylated normal background.
The majority (63%) of islands that include drift CpGs are
associated with gene promoter regions, i.e., they involve a
transcription start site (TSS200 or TSS1500), while only
11% of islands that undergo drift overlap with the gene
body, compared to 73% (TSS-associated) and 10% (body-
associated) CpG islands on the HM450 array, respectively.
In contrast, the relative abundance of intergenic CpG
islands is significantly higher among CpG islands that
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undergo drift compared to the fraction of intergenic CpG
islands found on the array (24 vs. 16%, see Fig. 1).
Out of 16,832 island-based (BE-specific) drift CpGs we
identified, 1317 unique CpG islands with 5 or more drift
CpGs per island (comprising a total of 11,425 drift
CpGs). Figure 2 presents a karyograph of 4 autosomes
indicating the genomic locations and mean β values for
these islands across the 64 BE samples (Additional file 1:
Figure S4 for all 22 autosomes). Figure 3 shows a
heatmap of the island-level mean β values of the 1317
drift-associated CpG islands for the first 10 NS tissue
samples, and all 64 BE samples used to identify CpG
probes undergoing drift. For this map, both CpG islands
and tissue samples were ordered by their respective
mean values. As expected, all 10 normal control tissue
samples show no island-level drift. In contrast, we see
significant heterogeneity in mean methylation levels of
these CpG islands ranging from < 20 to > 80% methyla-
tion across the 64 BE samples. With the notable excep-
tion of a group of samples that have undergone minimal
drift, most BE samples show bimodal patterns of drift
where some islands appear to linger at low levels and
others show advanced drift. We later use the following
categorization for the observed drift patterns in BE and
EAC: unimodal low drift (group L), bimodal high drift
with a major mode β > 50% (group H) and the
remaining bimodal intermediate drift (group I).
Pairwise correlations between island-associated CpGs
CpG islands are considered functional genomic units
that may exert transcriptional control by their collective
state of methylation rather than through individual CpG
sites. To demonstrate this collective behavior in an
island-level DNA methylation, we evaluated the pairwise
correlations between all island CpGs that are hypo-
methylated in NS tissue. In general, for static islands
(that do not show significant drift), pairwise correlations
are moderate (< 0.5) across the span of an island and ex-
hibit anti-correlations near and beyond the island
boundaries (Fig. 4). In contrast, island CpGs that drift
have stronger pairwise correlations reflecting a collective
response of these CpGs to drift consistent with proces-
sive DNA methylation maintenance [18, 19].
Figure 4 also shows that the pairwise correlations decay
with genomic distance and, for drift CpGs, extend further
into the island shelves than static CpGs. Islands that show
tissue age-related drift are also significantly larger (in
terms of genomic length) than static islands. The mean
Fig. 2 Representative karyographs of four autosomes. Chromosomes 2 and 12 exhibit typical methylomic drift patterns while chromosomes 17
and 19 exhibit high-density methylomic drift. Top track: chromosome banding. Middle track: array-based CpG island positions. Bottom track:
positions of CpG islands that undergo methylomic drift in 64 BE samples (mean levels color-coded)
Fig. 1 Proportion of CpGs and CpG islands that drift differentially in
Barrett’s esophagus vs. normal squamous (NS) esophagus among
over 146 k hypomethylated probes in NS tissue
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sizes of the static vs. drift CpG islands were 0.9 vs 1.1 kb,
respectively (p = 2 × 10−10, two-sided t test).
Bimodal nature of epigenetic drift in BE and EAC
To see whether methylomic drift is uniformly distributed
within our BE and EAC samples, we examined β value
distributions for a subset of island-associated drift CpGs
with a minimum of 5 detected drift CpGs per island
(11,425 drift CpGs in total) for 64 BE and 24 EAC samples
from the BETRNet (see “Methods”). Consistent with the
patterns seen in Fig. 3, these individual-level distributions
show signatures that fall into the arbitrary three types:
with unimodal distributions showing low or no drift
(group L), distinctly bimodal distributions with intermedi-
ate drift (both modes β < 0.5, group I), or bimodal with a
major mode near or above β = 0.5 and a minor mode at
lower levels (group H). (See Fig. 5a, for an aggregated view
of the samples in these groups). While the distributions
are similar for BE and EAC, EAC show more advanced
drift in the third group (bimodal high) which may be at-
tributed to EAC patients being on average older than the
BE patients (68 vs 62 years, respectively), or to the fact
that EAC undergoes more frequent stem cell divisions
thereby increasing replication-coupled de novo methyla-
tion, or to the possibility that BE arises earlier in patients
with EAC compared to patients who have not progressed
to dysplasia or EAC. We found similar unimodal/bimodal
drift signatures in 87 EAC from TCGA and in a combined
set of 19 BE and 47 EAC tissue samples provided by
Krause et al. [16] (GEO accession number: GSE72874).
Advanced drift is associated with low tumor stage
Using tumor stage information from the TCGA, we found
a statistically significant association (p value = 0.024; Fish-
er’s exact test) of low tumor stage (AJCC stage I) vs ad-
vanced stage (AJCC stage III and higher) with the type of
drift pattern (group H vs group L + I). Specifically, low-
stage tumors are more prevalent in group H compared with
group L + I among the 74 TCGA EAC for which tumor
stage information was available (odds ratio 6.0 (1.1–63.3)).
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Fig. 3 CpG island-level methylation heatmap (β values) of 1317 drift CpG islands (rows) and 10 NS and 64 non-dysplastic BE samples (columns)
ordered by their respective means. See text for details
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Fig. 4 Pairwise correlations between island-CpGs and other CpGs
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as a function of genomic distance at a resolution of 10 bp. “Static”
(nondrifting) CpG islands (black), drift-associated islands (red). Shaded
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Differential gene expression by drift group
To see whether gene expression patterns (at the mRNA
level) differed between EAC samples that showed minor
(unimodal low) drift and samples that showed advanced
methylomic drift on a gene by gene basis, we matched
1240 drift CpG islands (out of 1317 CpG islands with 5
or more drift CpGs per island) with one or more (over-
lapping) genes to evaluate the relationship between gene
expression and island-level methylation for the TCGA
and the Krause et al. data sets. Specifically, we identified
differentially expressed genes for which expression dif-
fered significantly between low- and high-drift samples
by setting a threshold of β = 0.2 to delineate the two
groups and using a two-sided Mann-Whitney-Wilcoxon
test (q < 0.01) on normalized gene expression data.
In total, we identified 200 genes that were significantly
underexpressed in the advanced drift group while only 10
genes were significantly overexpressed (Additional file 2:
Table S1). Independently, we found 35 genes that were sig-
nificantly repressed and none that were significantly over-
expressed among 51 (47 EAC + 4 BE) samples provided by
Krause et al. [16]. Importantly, several genes (20/35) that
were found repressed in the smaller study by Krause et al.
were also found repressed in TCGA (Additional file 2:
Table S1). In particular, the gene most significantly
repressed in TCGA (q = 5 × 10−9) was also ranked most
significantly repressed in the data provided by Krause et al.,
CHFR (checkpoint with forkhead and ring finger domains),
a mitotic stress checkpoint gene with tumor suppressive
function that has been identified in a wide range of cancers
[20, 21], and most recently as a significantly silenced gene
in a large clustering analysis of esophageal adenocarcinoma
[22]. This striking asymmetry between gene expression
changes and methylomic drift is consistent with parallel
findings that CpG promoter hypermethylation in cancers
often is correlated with gene-silencing [6]. A Gene Ontol-
ogy (GO)-based over-representation analysis using the
Database for Annotation, Visualization and Integrated Dis-
covery (DAVID) shows a highly significant greater than
threefold enrichment of sequence-specific DNA binding
transcription factor activity (p = 2 × 10−9, Additional file 2:
Table S2). The most prominent group identified by this
analysis is a family of repressive Krueppel-associated box
(KRAB) domain zinc finger (ZNF) transcription factors
(greater than sixfold, p = 1.3 × 10−15, Additional file 2: Table
S2). KRAB-mediated transcriptional repression involves the
binding of the KRAB domain to co-repressors potentially
resulting in heterochromatin formation and silencing of en-
dogenous retroviruses [23, 24].
Evidence for a threshold effect leading to bimodal drift
The drift patterns shown in Fig. 5a for BE and EAC sam-
ples suggest nonlinear drift dynamics in BE tissues. Spe-
cifically, the presence of a persistent mode in the drift
distribution at low levels (β < 0.2) is indicative of a
threshold below which drift is suppressed but advances
rapidly once the mean level is surmounted. To validate
that epigenetic drift occurs in our longitudinal samples
(20 patients with 2 biopsies each separated by at least 3–
4 years), we determined for each individual at two time
points the number of drift CpGs that remained below
(n11), respectively, the number that remained above
(n22), and the number of drift CpGs that had crossed the
threshold from low to high at β = 0.2 (n12) and, vice
versa, from high to low (n21). The results, including the
% fraction of drift CpGs advancing, n12/(n12 + n11), and
the % fraction retarding between the two time points,
n21/(n21 + n22), are listed in Additional file 2: Table S3
and shown as annual rates in Fig. 6. For 19/20 patients,
we detect greater methylation flow from sub-threshold
levels to higher levels at the second (later) biopsy com-
pared to flow in the opposite direction.
We note that these findings are surprisingly consistent
with the unimodal-to-bimodal epigenetic drift predictions
made by Sontag et al. [8] who proposed a mathematical
model that included a nonlinear relationship between de
novo methylation and the ambient level of methylation
present in a region of CpGs. To demonstrate that such a
model results in unimodal-to-bimodal drift transitions over
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time, we explicitly simulated sporadic de novo methylation
on an island of 50–100 CpGs, independently in 1000 cells,
mimicking crudely the cell population in the tissue samples.
Each CpG was assumed to be in a binary state (0/1 of being
(un)methylated), and the states of the CpGs initially (at
time t = 0) were sampled from a binomial distribution with
probability 0.06 which equals the mean methylation level in
our NS tissue samples. The CpG states were then propa-
gated stochastically with a rate (probability per time step)
of becoming methylated that increases 100-fold from a
background of 10−4 to 10−2 when the mean level of methy-
lation on the island crosses a threshold of β = 0.2.
Without a mathematical exploration of this Markov
model, but straightforward in silico experimentation
with the baseline distribution of methylation rates (spe-
cifically, a gamma distribution with mean 10−4 and vari-
ance 4 × 10−8) and threshold value, our simulations
show that this simple model generates methylation dens-
ity trajectories that typically bifurcate and strikingly re-
semble the observed drift signatures in our samples.
Figure 5b shows a typical density trajectory for a region
of 50 CpGs, an arrayed population of 1000 cells, every
100 time steps, for a total duration of 3000 time steps.
Although our model differs in functional form from the
model described in Sontag et al., it shares important fea-
tures, including a suppression of de novo methylation at
low levels and a nonlinear acceleration as the ambient
(regional) level of methylation increases. In contrast,
models that do not include this ambient methylation
feedback on the local (site-specific) rate of methylation
do not, in general, lead to bifurcations in the main (ini-
tial) mode of the evolving drift pattern, but still exhibit a
weak bimodality as shown in Additional file 1: Figure S2.
Additional file 1: Figure S3 further illustrates the
stochastic nonlinear behavior of our model via simulated
time course trajectories of the mean methylation levels
for 10 CpG islands that share an identical drift rate dis-
tribution across their CpGs.
Discussion
Here we take a closer look at how differential epigenetic
drift is organized in BE-associated genomes, and its
scope and association with gene expression, motivating
further investigation of its role in neoplastic progression
in BE. To do so, we first surveyed the array-based DNA
methylome for significant correlations with the mean
drift measured by 67 drift CpGs previously identified by
our group to estimate BE dwell time, i.e., the time a pa-
tient has lived with BE [12, 13]. Following this study, we
targeted CpGs that are hypomethylated in NS tissue but
are subject to differential drift in BE tissue caused by ac-
celerated age-related de novo methylation. While NS tis-
sue may not be the tissue of origin for BE, the similarity
of methylation levels at drift-associated CpGs between
NS and other normal tissues, such as fundus (see Add-
itional file 1: Figure S1), justifies the use of NS as a nor-
mal reference tissue to identify differential drift in BE.
Our previous study did not reveal the full extent of this
differential drift due to highly restrictive pre-filtering.
Our genome-wide “drift survey” revealed that, at the is-
land level, > 24% of CpG islands undergo methylomic drift
and are predominantly promoter-associated (i.e., overlap
transcription start sites (TSS)). To investigate whether epi-
genetic drift occurs on isolated CpG sites or is a nonlocal
phenomenon at the CpG island level, we evaluated corre-
lations of methylation between pairs of CpGs (across BE
samples) using all island-associated CpG probes (available
on the HM450 platform) as a function of genomic dis-
tance between the probes (Fig. 4). Our results confirm the
prevailing view that CpG islands essentially exert epigen-
etic control by their collective methylation state rather
than through specific CpG sites [25, 26]. Importantly, we
found evidence that drift does not evolve uniformly in BE
and EAC but appears to be governed by a nonlinear,
threshold-like stochastic methylation process which de-
pends nonlocally on the methylation status of other island
CpGs. Simulations using a stochastic model, which re-
flects these dynamics at the island level, show characteris-
tic transitions from unimodal to bimodal drift similar to
what we observe in our data. Although other models may
provide similar fits to the observed drift distributions, this
model has its origins in earlier work aimed at understand-
ing the stable, somatic inheritance of methylation imprints
[8] and predicts epigenetic drift as a series of sporadic de
novo methylation events at the island level. Our nonlinear
feedback model for methylomic drift suggests that the
various drift distributions we see in our tissue samples
may simply be attributed to tissue age itself (i.e., at what
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points in time the tissue samples were obtained during the
dynamic process of methylomic evolution). Furthermore,
analyses of consecutive biopsies in the same patient sepa-
rated by several years further confirmed that epigenetic
drift, as defined in this study, involves the sporadic depart-
ure from normal (hypomethylated) levels to higher levels
as the tissue ages. Taken together, these findings suggest
that epigenetic drift in BE advances non-uniformly by
departing from unimodal (low-drift) distributions of
methylation and gradually bifurcating into bimodal distri-
butions over time. Similar unimodal and bimodal methy-
lation distributions are observed in EAC samples although
the bimodality appears more pronounced in EAC.
To investigate potential functional consequences of epi-
genetic drift, we compared gene expression in BE and EAC
samples showing no (or low) drift to gene expression in
samples that show definite drift β > 0.2. This comparison
revealed statistically significant differences in gene
expression between the two sample groups that are pre-
dominantly repressive involving several checkpoint and
tumor suppressor-like genes, in particular CHFR (check-
point with forkhead and ring finger domains), a mitotic
stress checkpoint gene that has been observed to undergo
promoter-associated hypermethylation in colon, gastric, and
esophageal cancers and is associated with chromosomal in-
stability [27, 28]. Submitting the 200 differentially repressed
genes in the TCGA EAC samples to a statistical over-
representation test (Additional file 2: Table S2) further re-
vealed an unexpected high number of KRAB domain zinc
finger genes (greater than sixfold enrichment using DAVID)
that are subject to epigenetic drift and transcriptional re-
pression possibly compromising their KAP1(TRIM28)-me-
diated repressive function. This finding is intriguing because
KRAB domain ZNF also target endogenous retroviruses
and transposable elements.
Finally, comparison of island-level drift with gene ex-
pression in NS and BE tissue samples from the Krause
study [16] revealed that the majority of genomic loci
undergoing epigenetic drift in BE are transcriptionally si-
lent, consistent with the notion of neutral (clock-like)
drift. However, the majority of differentially expressed
genes associated with CpG islands that exhibit advanced
drift are repressed in EAC when methylation levels in-
crease beyond a threshold of approximately 20%. These
findings support the hypothesis that neoplasia, such as
dysplastic BE and EAC, may develop in response to epi-
genetically driven selective pressure exerted on gene ex-
pression as methylation levels (on CpG islands
associated with gene promoters) advance via random
drift beyond a critical, repressive threshold.
Conclusions
Our results are consistent with the hypothesis that
epigenetic drift heralds the onset of (epi)genomic
instability via bifurcations (as seen in Fig. 5) that as-
sociate with the transcriptional repression of import-
ant regulatory genes [29–32]. Thus, under this
hypothesis, epigenetic drift not only defines tissue
aging (i.e., provides a molecular clock) but also
“throttles” the expression and function of develop-
mental genes forcing transitions in tissue characteris-
tics that better cope with the erosive and damaging
milieu in BE. Further studies of whether changes in
methylomic drift simply reflect transcriptional
changes during neoplastic progression or induce
such changes are therefore of critical importance to
better understand mechanisms that drive age-related
cancer evolution.
Methods
Tissue samples
Formalin fixed paraffin-embedded (FFPE) tissue
slides and cores were obtained from Case Western
Reserve University/University Hospitals of Cleveland
(Cleveland, OH) and the Cleveland Clinic (CC)
following protocols approved by the Institutional
Review Board of each institution. For the cross-
sectional analysis, we used HM450 methylation array
data from 52 NS, 64 nondysplastic BE, and 24 EAC
samples through the Barrett’s Esophagus Transla-
tional Research Network (BETRNet) [33]. For the
longitudinal drift analysis, we utilized 33 additional
tissue samples from two studies with 10 patients
each (CC and CW). Each patient had two biopsies
separated by at least 3–4 years (40 samples total). Of
these, seven samples were included in the cross-
sectional analysis. See Additional file 2: Table S4 for
relevant clinical information on the patient samples
used in this study.
Sample pre-processing
Tissue sample preparation and DNA extraction were
performed as described previously [34]. The quality
of DNA extracted from FFPE samples were deter-
mined with Illumina HD FFPE QC assay (Illumina,
San Diego, USA) following the manufactures’ in-
structions. Two hundred fifty nanograms of DNA
samples that passed the QC assay were bisulfite con-
verted using the EZ DNA Methylation Kit (Zymo
Research, Irvine, USA). DNA restoration was per-
formed using the Illumina HD FFPE Restoration Kit
(Illumina, San Diego, USA) according to the manu-
facturer’s instructions. Intermediate DNA purifica-
tions were performed using the Zymo DNA Clean
and Concentrator-5 Kit (Zymo Research, Irvine,
USA). The BETRNet DNA samples were run on Illu-
mina HumanMethylation450 BeadChip (HM450) ar-
rays following the manufacturer’s instructions
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(Illumina Inc.) at the Fred Hutch Genomics Core fa-
cility. Data were then accessed as raw two-color
channel intensities in idat format and pre-processed.
Arrays were normalized using two functions imple-
mented in the minfi (v1.18.6) R module, including
an initial background intensity correction identical to
the correction implemented in Illumina’s Genome
Studio software, followed by subset quantile within-
array normalization (SWAN) to harmonize data
across assay design types [35, 36]. Probes showing
mean detection p value > 0.05 were filtered out. Fur-
thermore, we checked for the presence of previously
identified cross-reactive CpGs in our drift CpG sets.
Our drift CpG sets are uniformly under-enriched for
cross-reactive probes, and we found that the pres-
ence of cross-reactive probes did not affect the in-
tegrity of our findings.
Methylation and gene expression datasets
Matched methylation (HM450 platform) and gene ex-
pression (Illumina HumanHT-12V4.0 expression Bead-
Chip platform) data collected for 4 BE and 47 EAC, and
17 normal esophagus tissue samples published by [16]
were accessed via the Gene Expression Omnibus (GEO)
online repository (Series GSE72874). Methylation and
expression BeadChip array data were obtained as nor-
malized and filtered intensity counts or β values and
prepared as described in [16].
Additional validation data, including HM450 array
methylation and Illumina HiSeq 2000 RNA Sequencing
data from the Version 2 analysis pipeline, were obtained
for samples provided by the Cancer Genome Atlas
(TCGA) via the NCI Genomic Data Commons [37] and
the Firehose resource hosted by the Broad Institute
(http://gdac.broadinstitute.org/). HM450 array data were
obtained as raw two-color channel intensity readings,
which were subjected to the same pre-processing pipe-
line as the BETRNet cohort data, described above. RNA-
seq expression sequencing data was obtained as level 3
RNAseq by expectation maximization (RSEM)-normal-
ized and pre-processed intensity counts [38]. A nonpara-
metric Mann-Whitney-Wilcoxon (MWW) U test was
applied to gene-specific count data to detect differential
gene expression between low methylation samples
(β < 0.2) and advanced methylation samples (β ≥ 0.2).
Quantification of drift
The methylation state of a CpG dinucleotide on a
specific chromosome is essentially a binary variable;
the cytosine is either methylated or unmethylated.
However, DNA methylation arrays (such as the Illu-
mina HM450 beadchip) provide only aggregate meas-
urement across thousands of cellular epigenomes in a
given tissue sample and therefore can only provide
population fractions (i.e., β values) of methylated
probes expressed as the ratio β = M/(M + U), with
M and U representing the number of methylated and
unmethylated probes in the sample, respectively.
Genome-wide differential epigenetic drift in BE
was quantified by scanning over 146,000 hypomethy-
lated CpG probes (β < 0.25 in NS tissue) on the
HM450 platform for significant correlations with the
mean methylation levels of 67 CpGs previously iden-
tified to drift differentially between BE and matched
NS tissue samples from 30 BE patients [12]. Note,
the differences in mean M values (defined as logit2(β
value)) of the 67 drift CpGs reflect patient-specific
differences in individual BE tissue dwell times as de-
scribed in [12]. Figure 7 illustrates the two-step
method used to identify CpG probes that were sig-
nificantly correlated with this BE tissue clock: (1) we
computed the mean M value drift over the 67 BE
clock probes for each of the 64 cross-sectional BE
samples and (2) for each CpG in the hypomethylated
test set (146,029 CpG probes), we obtained the Pear-
son correlation and p value using the cor.test R-
function. Only CpG probes that were significantly
(q < 0.01) and positively (r > 0.5) correlated with the
BE tissue clock were retained and formed the set of
18,013 island and non-island-based drift CpGs used
in this study.
Statistical analysis and visualization
All data pre-processing and the majority of statistical
testing was performed in R programming language with
base R graphics and analysis functions (v3.3.0). The
minfi (v1.18.6) and GEOquery (v2.38.4) Bioconductor
modules were used to access, pre-process, normalize,
and analyze both methylation and gene expression array
data, respectively [35, 39, 40].
Data access
Data prepared for this study are available online at the
GEO website (Series Number: GSE104707). Scripts for
study analyses and visualizations are available at https://
github.com/gluebeck/Scope-of-methylomic-drift-in-BE.
Fig. 7 See “Methods”
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Additional files
Additional file 1: Figure S1. Boxplot of normal squamous (NS)
methylation fine-structure (represented using M values) for five repre-
sentative, consecutively positioned CpGs at the MGMT (O-6-methyl-
guanine-DNA methyltransferase) gene which overlaps a CpG-rich
island at chr10:131264948-131265710. Mean methylation fractions
(n = 52) range from 1% (lowest) to 19% (highest) for the five
promoter-associated CpGs shown. Superimposed are the M values of
12 normal tissue samples collected in fundus (red). Nearly identical
methylation patterns were observed in normal colon samples (not
shown). Figure S2. Simulated methylation densities (arbitrary time
scale) using a linear drift model without ambient methylation feed-
back on the rate of site-specific methylation. Figure S3. Simulated tra-
jectories of mean methylation levels for 10 islands with 50 CpGs
each under the nonlinear (threshold) model described in the main
text. As methylation levels approach the threshold of β = 0.2, rapid
stochastic transitions occur followed by accelerated drift. Figure S4
Karyograph showing locations of methylomic drift across 64 BE sam-
ples for all 22 autosomes. Figure S5. The same as Fig. 5a, but for 87
EAC from TCGA. (DOCX 863 kb)
Additional file 2: Table S1. List of genes with differential expression
among low- and high-drift samples in TCGA (n = 87) using a β value
threshold of 0.2 to delineate the two groups. Two hundred genes
were significantly underexpressed in the advanced drift group, 15
genes (not shown) were significantly overexpressed (q < 0.01, Mann-
Whitney-Wilcoxon two-sided test). Highlighted genes were also found
to be independently and significantly underexpressed in the com-
bined set of 47 EAC and 4 BE samples for which both gene expres-
sion and DNA methylation data were available used by Krause et al.
(Carcinogenesis 37(4), 2016). Table S2. DAVID enrichment analysis (by
protein class) of the 200 repressed genes listed in Additional file 2:
Table 1. Highlighted protein classes are significantly enriched. Table
S3 CpG dinucleotide methylation transition rates for 20 patients with
longitudinally collected BE biopsy samples separated by at least 3–
4 years, including 10 patients from BETRNet/CC and 10 patients from
BETRNet/CW. A threshold of β = 0.2 was used to classify CpG methy-
lation as low (1) or high (2). The first two columns provide patient
ages at biopsy, third is a patient label, columns 4–7 represent CpG
fractions that begin and end at low methylation (n11), transition from
high to low (n21), transition from low to high (n12), and remain high
(n22). Conditional transition fractions are in columns 8–11, and annual
increasing and decreasing methylation rates are in columns 12–13.
Table S4. Patient ID (encoded), project (BETRNet/MEMO), tissue type
(normal squamous (NS), Barrett’s esophagus (BE), esophageal adeno-
carcinoma (EAC)), sex, age at biopsy, and patient diagnosis (Dx) at
the time of biopsy. (DOCX 723 kb)
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